GB201812334D0 - Compositions and uses thereof - Google Patents

Compositions and uses thereof

Info

Publication number
GB201812334D0
GB201812334D0 GBGB1812334.9A GB201812334A GB201812334D0 GB 201812334 D0 GB201812334 D0 GB 201812334D0 GB 201812334 A GB201812334 A GB 201812334A GB 201812334 D0 GB201812334 D0 GB 201812334D0
Authority
GB
United Kingdom
Prior art keywords
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1812334.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Exeter
Original Assignee
University of Exeter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Exeter filed Critical University of Exeter
Priority to GBGB1812334.9A priority Critical patent/GB201812334D0/en
Publication of GB201812334D0 publication Critical patent/GB201812334D0/en
Priority to PCT/GB2019/052125 priority patent/WO2020021291A1/en
Priority to JP2021504393A priority patent/JP2021531317A/ja
Priority to CN202411972083.0A priority patent/CN120713925A/zh
Priority to CN201980064286.0A priority patent/CN113166214A/zh
Priority to US17/263,465 priority patent/US20210292765A1/en
Priority to AU2019309587A priority patent/AU2019309587B2/en
Priority to CA3107700A priority patent/CA3107700A1/en
Priority to KR1020217006078A priority patent/KR20210069626A/ko
Priority to EP19745738.5A priority patent/EP3830111A1/en
Priority to JP2024076795A priority patent/JP2024102292A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/323—Chemical structure of the sugar modified ring structure
    • C12N2310/3233—Morpholino-type ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/31—Combination therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
GBGB1812334.9A 2018-07-27 2018-07-27 Compositions and uses thereof Ceased GB201812334D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB1812334.9A GB201812334D0 (en) 2018-07-27 2018-07-27 Compositions and uses thereof
EP19745738.5A EP3830111A1 (en) 2018-07-27 2019-07-29 Compositions comprising intermediate non-coding rna regulators modulating the expression of etv6 or foxo1 and uses thereof
CN201980064286.0A CN113166214A (zh) 2018-07-27 2019-07-29 包含调节etv6或foxo1表达的中间非编码rna调节剂的组合物及其用途
JP2021504393A JP2021531317A (ja) 2018-07-27 2019-07-29 Ｅｔｖ６またはｆｏｘｏ１の発現を調節する中間体ノンコーディングｒｎａ制御因子を含む組成物およびその使用
CN202411972083.0A CN120713925A (zh) 2018-07-27 2019-07-29 包含调节etv6或foxo1表达的中间非编码rna调节剂的组合物及其用途
PCT/GB2019/052125 WO2020021291A1 (en) 2018-07-27 2019-07-29 Compositions comprising intermediate non-coding rna regulators modulating the expression of etv6 or foxo1 and uses thereof
US17/263,465 US20210292765A1 (en) 2018-07-27 2019-07-29 Compositions comprising intermediate non-coding rna regulators modulating the expression of etv6 or foxo1 and uses thereof
AU2019309587A AU2019309587B2 (en) 2018-07-27 2019-07-29 Compositions comprising intermediate non-coding RNA regulators modulating the expression of ETV6 or FOXO1 and uses thereof
CA3107700A CA3107700A1 (en) 2018-07-27 2019-07-29 Compositions comprising intermediate non-coding rna regulators modulating the expression of etv6 or foxo1 and uses thereof
KR1020217006078A KR20210069626A (ko) 2018-07-27 2019-07-29 Etv6 또는 foxo1의 발현을 조절하는 중간체 비-코딩 rna 조절인자를 포함하는 조성물 및 이의 용도
JP2024076795A JP2024102292A (ja) 2018-07-27 2024-05-09 Ｅｔｖ６またはｆｏｘｏ１の発現を調節する中間体ノンコーディングｒｎａ制御因子を含む組成物およびその使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1812334.9A GB201812334D0 (en) 2018-07-27 2018-07-27 Compositions and uses thereof

Publications (1)

Publication Number Publication Date
GB201812334D0 true GB201812334D0 (en) 2018-09-12

Family

ID=63518136

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1812334.9A Ceased GB201812334D0 (en) 2018-07-27 2018-07-27 Compositions and uses thereof

Country Status (9)

Country Link
US (1) US20210292765A1 (enExample)
EP (1) EP3830111A1 (enExample)
JP (2) JP2021531317A (enExample)
KR (1) KR20210069626A (enExample)
CN (2) CN120713925A (enExample)
AU (1) AU2019309587B2 (enExample)
CA (1) CA3107700A1 (enExample)
GB (1) GB201812334D0 (enExample)
WO (1) WO2020021291A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4328587A3 (en) * 2018-02-13 2024-06-05 Toray Industries, Inc. Use of a kit or device and method for detecting dementia
CA3167206A1 (en) * 2020-02-14 2021-10-07 The Board Of Trustees Of The Leland Stanford Junior University Pan-genotypic agents against respiratory viruses and methods of using the same
CN114159457B (zh) * 2021-12-03 2023-08-22 温州医科大学 一种长链非编码rna、其结合蛋白及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0225799D0 (en) * 2002-11-05 2002-12-11 Novartis Forschungsstiftung Tel/etv6-mediated inhibition of cell proliferation
EP1907016A2 (en) * 2005-07-11 2008-04-09 Irm, Llc Methods and composition for modulating foxo1 activity and insulin signaling
JP2013253031A (ja) * 2012-06-06 2013-12-19 Nissei Bio Kk 抗老化関連遺伝子転写促進剤
US11657895B2 (en) * 2016-05-03 2023-05-23 Institute For Systems Biology Methods for identifying treatment targets based on multiomics data

Also Published As

Publication number Publication date
AU2019309587A1 (en) 2021-02-18
US20210292765A1 (en) 2021-09-23
JP2021531317A (ja) 2021-11-18
CN120713925A (zh) 2025-09-30
WO2020021291A1 (en) 2020-01-30
EP3830111A1 (en) 2021-06-09
CA3107700A1 (en) 2020-01-30
KR20210069626A (ko) 2021-06-11
AU2019309587B2 (en) 2024-09-19
CN113166214A (zh) 2021-07-23
JP2024102292A (ja) 2024-07-30

Similar Documents

Publication Publication Date Title
SG11202100071YA (en) Fusosome compositions and uses thereof
SG11202011015QA (en) Fusosome compositions and uses thereof
IL279755A (en) Senolytic preparations and their uses
IL271275A (en) Preparations containing coronas and their uses
GB2578519B (en) Compositions and methods and uses relating thereto
IL277663A (en) Arunumab preparations and their uses
GB201817444D0 (en) Methods and compositions
GB201815402D0 (en) Compositions and methods and uses relating thereto
GB201812334D0 (en) Compositions and uses thereof
GB201807576D0 (en) Compositions and uses thereof
GB201804092D0 (en) Methods and compositions
GB201712592D0 (en) Novel compositions and uses thereof
GB201821138D0 (en) Compositions and uses thereof
GB201812952D0 (en) Compositions and uses thereof
GB201821144D0 (en) Compositions and uses thereof
GB201819493D0 (en) Compositions and uses thereof
GB201818495D0 (en) Compositions and uses thereof
GB201818375D0 (en) Compositions and uses thereof
GB201808858D0 (en) Compositions and uses thereof
GB201808907D0 (en) Compositions and uses thereof
GB201808321D0 (en) Compositions and uses thereof
GB201808298D0 (en) Compositions and uses thereof
GB201805322D0 (en) Compositions and uses thereof
GB201805093D0 (en) Compositions and uses thereof
GB201805097D0 (en) Compositions and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)